DK0541753T3 - Hidtil ukendt hybrid, opløselig og ikke-spaltelig gp160-variant - Google Patents
Hidtil ukendt hybrid, opløselig og ikke-spaltelig gp160-variantInfo
- Publication number
- DK0541753T3 DK0541753T3 DK92910881.9T DK92910881T DK0541753T3 DK 0541753 T3 DK0541753 T3 DK 0541753T3 DK 92910881 T DK92910881 T DK 92910881T DK 0541753 T3 DK0541753 T3 DK 0541753T3
- Authority
- DK
- Denmark
- Prior art keywords
- hiv
- region
- strain
- cleavable
- soluble
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/16011—Human Immunodeficiency Virus, HIV
- C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
- C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Virology (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Immunology (AREA)
- Gastroenterology & Hepatology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Biochemistry (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Engineering & Computer Science (AREA)
- Tropical Medicine & Parasitology (AREA)
- AIDS & HIV (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Curing Cements, Concrete, And Artificial Stone (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
- Saccharide Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR919105392A FR2676071B1 (fr) | 1991-05-02 | 1991-05-02 | Nouveau variant gp160 non-clivable, soluble, de forme hybride. |
Publications (1)
Publication Number | Publication Date |
---|---|
DK0541753T3 true DK0541753T3 (da) | 1997-08-04 |
Family
ID=9412448
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK92910881.9T DK0541753T3 (da) | 1991-05-02 | 1992-04-30 | Hidtil ukendt hybrid, opløselig og ikke-spaltelig gp160-variant |
Country Status (12)
Country | Link |
---|---|
US (2) | US6261799B1 (es) |
EP (1) | EP0541753B1 (es) |
JP (1) | JP3453611B2 (es) |
AT (1) | ATE149203T1 (es) |
CA (1) | CA2086509C (es) |
DE (1) | DE69217614T2 (es) |
DK (1) | DK0541753T3 (es) |
ES (1) | ES2099257T3 (es) |
FR (1) | FR2676071B1 (es) |
GR (1) | GR3023070T3 (es) |
SG (1) | SG44828A1 (es) |
WO (1) | WO1992019742A1 (es) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0890642A3 (de) * | 1992-10-06 | 2000-09-13 | Dade Behring Marburg GmbH | Retrovirus aus der HIV-Gruppe und dessen Verwendung |
DK0679187T4 (da) * | 1993-01-16 | 2001-09-17 | Manfred Schawaller | Fremgangsmåde til udvinding af native, oligomere, glycosylerede ektodomæner fra virale membranproteiner, og deres anvendelse, især som vaccine mod HIV |
DE4405810A1 (de) | 1994-02-23 | 1995-08-24 | Behringwerke Ag | Von einem Retrovirus aus der HIV-Gruppe abgeleitete Peptide und deren Verwendung |
AU3334001A (en) | 2000-02-10 | 2001-08-20 | Panacos Pharmaceuticals Inc | Assay for detection of viral fusion inhibitors |
WO2009011912A1 (en) * | 2007-07-18 | 2009-01-22 | Bristol-Myers Squibb Company | A composition for treating hiv comprising virus-like particles |
CA2834288A1 (en) * | 2011-04-25 | 2012-11-01 | Advanced Bioscience Laboratories, Inc. | Truncated hiv envelope proteins (env), methods and compositions related thereto |
EP2869842A1 (en) * | 2012-07-06 | 2015-05-13 | Novartis AG | Immunogenic compositions and uses thereof |
WO2016196471A1 (en) | 2015-06-02 | 2016-12-08 | Cooper Human Systems Llc | Methods and compositions for treatment of hiv infection |
WO2019097466A1 (en) | 2017-11-17 | 2019-05-23 | Grifols Diagnostic Solutions Inc. | Novel mammalian expressed human immunodeficiency virus envelope protein antigens |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5169763A (en) * | 1986-04-08 | 1992-12-08 | Transgene S.A., Institut Pasteur | Viral vector coding glycoprotein of HIV-1 |
FR2606029B2 (fr) * | 1986-04-08 | 1989-02-03 | Transgene Sa | Vecteur viral et adn recombinant codant pour une glycoproteine du virus agent causal du s.i.d.a., culture cellulaire infectee par ce vecteur, procede de preparation de la glycoproteine, glycoproteine obtenue, vaccin et anticorps obtenus |
EP0272858A3 (en) * | 1986-12-15 | 1989-07-12 | Repligen Corporation | Recombinant hiv envelope proteins produced in insect cells |
FR2620030B1 (fr) * | 1987-09-07 | 1990-03-23 | Transgene Sa | Vecteur d'expression des proteines du virus hiv-2, un agent causal du sida, culture cellulaire infectee ou transformee par ce vecteur, proteines obtenues, vaccin et anticorps obtenus |
IL89567A0 (en) * | 1988-03-28 | 1989-09-10 | Univ Leland Stanford Junior | Mutated hiv envelope protein |
CA2003383A1 (en) * | 1988-11-23 | 1990-05-23 | Sushil G. Devare | Synthetic dna derived recombinant hiv antigens |
DE69031735T2 (de) * | 1989-04-18 | 1998-03-12 | Applied Biotechnology Inc | Erzeugung von hybrid-genen und proteinen durch rekombination mittels viren |
FR2650954B1 (fr) * | 1989-08-18 | 1992-02-28 | Pasteur Institut | Composition resultant de la reunion d'un epitope b de la glycoproteine d'enveloppe d'un retrovirus du type iv et d'un epitope t issu d'une proteine distincte codee par ce retrovirus et leur application a la production d'anticorps protecteurs contre le sida |
GB8923123D0 (en) * | 1989-10-13 | 1989-11-29 | Connaught Lab | A vaccine for human immunodeficiency virus |
IE904083A1 (en) * | 1989-11-13 | 1991-05-22 | Cambridge Biotech Corp | Diagnostic proteins to test for more than one antibody |
WO1991015238A1 (en) * | 1990-04-03 | 1991-10-17 | Genentech, Inc. | Methods and compositions for vaccination against hiv |
-
1991
- 1991-05-02 FR FR919105392A patent/FR2676071B1/fr not_active Expired - Fee Related
-
1992
- 1992-04-30 SG SG1996008345A patent/SG44828A1/en unknown
- 1992-04-30 DK DK92910881.9T patent/DK0541753T3/da active
- 1992-04-30 WO PCT/FR1992/000394 patent/WO1992019742A1/fr active IP Right Grant
- 1992-04-30 ES ES92910881T patent/ES2099257T3/es not_active Expired - Lifetime
- 1992-04-30 CA CA002086509A patent/CA2086509C/fr not_active Expired - Lifetime
- 1992-04-30 US US07/956,483 patent/US6261799B1/en not_active Expired - Lifetime
- 1992-04-30 AT AT92910881T patent/ATE149203T1/de active
- 1992-04-30 DE DE69217614T patent/DE69217614T2/de not_active Expired - Lifetime
- 1992-04-30 EP EP92910881A patent/EP0541753B1/fr not_active Expired - Lifetime
- 1992-04-30 JP JP50983392A patent/JP3453611B2/ja not_active Expired - Lifetime
-
1995
- 1995-06-07 US US08/472,240 patent/US6284248B1/en not_active Expired - Lifetime
-
1997
- 1997-04-08 GR GR970400738T patent/GR3023070T3/el unknown
Also Published As
Publication number | Publication date |
---|---|
CA2086509A1 (fr) | 1992-11-03 |
ES2099257T3 (es) | 1997-05-16 |
FR2676071A1 (fr) | 1992-11-06 |
WO1992019742A1 (fr) | 1992-11-12 |
DE69217614D1 (de) | 1997-04-03 |
CA2086509C (fr) | 2003-07-01 |
JP3453611B2 (ja) | 2003-10-06 |
US6284248B1 (en) | 2001-09-04 |
ATE149203T1 (de) | 1997-03-15 |
EP0541753A1 (fr) | 1993-05-19 |
US6261799B1 (en) | 2001-07-17 |
DE69217614T2 (de) | 1997-07-10 |
GR3023070T3 (en) | 1997-07-30 |
EP0541753B1 (fr) | 1997-02-26 |
JPH05508324A (ja) | 1993-11-25 |
SG44828A1 (en) | 1997-12-19 |
FR2676071B1 (fr) | 1994-11-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE380822T1 (de) | Funf-helix protein | |
NO20025153L (no) | Fremgangsmåter og sammensetninger for å påvirke formering av HIV-1, HIV-2 og SIV | |
MY136081A (en) | Modified hiv - 1gag p17 peptide and immunogenic composition | |
NO891711L (no) | Hiv env-kodet peptid som er istand til aa fremkalle hiv-inhiberende antistoffer i pattedyr. | |
ATE135743T1 (de) | Monoklonale menschliche antikörper gegen hiv-i | |
PT1159298E (pt) | Péptidos de hiv, antigénios, composições de vacinas, kit de imunoensaio e um método de detecção de anticorpos induzidos por hiv | |
BR9500732B8 (pt) | Kit diagnóstico para a detecção de anticorpos contra vírus que causam imunodeficiência. | |
DK0541753T3 (da) | Hidtil ukendt hybrid, opløselig og ikke-spaltelig gp160-variant | |
Nygren et al. | 95-and 25-kDa fragments of the human immunodeficiency virus envelope glycoprotein gp120 bind to the CD4 receptor. | |
EP0255190A3 (en) | Recombinant polypeptides and their uses, inclusing assay for aids virus | |
ATE199394T1 (de) | Gag-env fusion-antigen aus hiv | |
ES2156902T3 (es) | Peptidos que inducen la produccion de anticuerpos neutralizantes contra cepas de vih-1 geneticamente divergentes. | |
ES2074591T3 (es) | Expresion de polipeptidos de vih 1 y 2 y su utilizacion. | |
AU8976691A (en) | Selected peptides of the group-specific antigen (gag) of human immunodeficiency virus (hiv), the preparation and use thereof | |
ATE119166T1 (de) | An hiv relatierte peptide. | |
DK0462551T3 (da) | Monoklonale antistoffer mod HIV gp120 | |
DK284389A (da) | Precursorantigener |